Abstract
The surgical treatment of obesity is a consideration for individuals with severe obesity or obesity related comorbid conditions who have been unsuccessful in their effort to accomplish effective weight loss. Weight loss surgery is the most effective treatment for severe medical complicated and refractory obesity. Although there is a risk of postoperative complications, perioperative mortality is rare. It significantly ameliorates numerous life-threatening medical comorbidities that occur as part of the pathophysiology of obesity. Rapid changes in surgical technology and in demand for weight loss surgery have made the field one of medicines most dynamic. This chapter reviews available surgical procedures with possible mechanisms of action through the entero-hypothalamic endocrine axis, and their risks and outcomes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jensen MD, Ryan DH, Apovian CM, Loria CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol. 2013. [Epub ahead of print]
Nguyen NT, Slone JA, Nguyen XM, Hartman JS, Hoyt DB. A prospective randomized trial of laparoscopic gastric bypass versus laparoscopic adjustable gastric banding for the treatment of morbid obesity: outcomes, quality of life, and costs. Ann Surg. 2009;250(4):631–41.
Buchwald H. The future of bariatric surgery. Obes Surg. 2005;15:598–605.
Livingston E, Bruchell I. Reduced access to care resulting from centers excellence initiatives in bariatric surgery. Arch Surg. 2010;145(10):993–7.
Jensen MD, Ryan DH. New obesity guidelines: promise and potential. JAMA. 2014;311(1):23–4.
The Look AHEAD Research Group. Research Group. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus. Four-year results of the Look AHEAD Trial. Arch Intern Med. 2010;170(17):1566–73.
Look AHEAD Research Group. Eight-year weight losses with an intensive lifestyle intervention: the Look AHEAD study. Obesity (Silver Spring). 2014;22(1):5–13.
Yanovski SZ, Yanovski JA. Long-term drug treatment for obesity: a systematic and clinical review. JAMA. 2014;311(1):74–86.
Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222(3):339–50.
Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52.
Courcoulas AP, Christian NJ, Belle SH. Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA. 2013;310(22):2416–25.
Ikramuddin S, Korner J, Lee WJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA. 2013;309(21):2240–9.
Smith BR, Schauer P, Nguyen NT. Surgical approaches to the treatment of obesity: bariatric surgery. Med Clin North Am. 2011;95(5):1009–30.
Madsbad S, Dirksen C, Hoist JJ. Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery. Lancet Diabetes Endocrinol. 2014;2:152–64.
Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346:1623–30.
Naslund E, Kral JG. Impact of gastric bypass surgery on gut hormones and glucose homeostasis in Type 2 diabetes. Diabetes. 2006;55 Suppl 2:S92–7.
Le Roux CW, Aylwin SJ, Batterham RL, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg. 2006;243:104–14.
Dar MS, Chapman 3rd WH, Pender JR, et al. GLP-1 response to mixed meal: what happens 10 years after Roux-en-Y gastric bypass (RYGB)? Obes Surg. 2013;22(7):1077–83.
Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery vs intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76.
Himpens J, Dobbeleir J, Peeters G. Long-term results of laparoscopic sleeve gastrectomy for obesity. Ann Surg. 2010;252:319–24.
Kotzampassi K, Shrewsbury AD, Papakostas P, Penna S, Tsaousi GG, Grosomanidis V. Looking into the profile of those who succeed in losing weight with an intragastric balloon. J Laparoendosc Adv Surg Tech A. 2014;24(5):295–301.
Genco A, Bruni T, Doldi SB, et al. BioEnterics Intragastric Balloon: the Italian experience with 2,515 patients. Obes Surg. 2005;15:1161–4.
Herve J, Wahlen CH, Schaeken A, et al. What becomes of patients one year after the intragastric balloon has been removed? Obes Surg. 2005;15:864–70.
Flum DR, Belle SH, King WC. The Longitudinal Assessment of Bariatric Surgery (LABS) Consortium, et al. Perioperative safety in the longitudinal assessment of bariatric surgery N Engl J Med. 2009;361(5): 445–54.
Chang SH, Stoll CR, Song J, Varela JE, Eagon CJ, Colditz GA. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg. 2014;149(3):275–87. doi:10.1001/jamasurg.2013.3654.
Laferrere B, Teixeira J, McGinty J, et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab. 2008;93(7):2479–85.
Wolfe BM, Purnell JQ, Belle SH. Treating diabetes with surgery. JAMA. 2013;309:2274–5.
Adams TD, Hunt SC. Cancer and obesity: effect of bariatric surgery. World J Surg. 2009;33(10):2028–33.
Stefaniak TJ, Håkansson IG, Ahlström M, Sandström A, Proczko-Markuszewska M. Comparison of cancer risk reduction after bariatric surgery demands an adequate control group. Ann Surg. 2013 [Epub ahead of print]
Cremieux PY, Ghosh A, Yang HE, Guessing M, Buchwald H, Shikora SA. Return on investment for bariatric surgery. Am J Manag Care. 2008;14(11):e5–6.
Blackburn GL, Waltman BA. Obesity and insulin resistance. In: McTiernan A, editor. Cancer prevention and management through exercise and weight control, vol. 20. New York: Marcel Dekker; 2005. p. 301–16.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Wolfe, B.M., Blackburn, G.L., Sanchez, V.M. (2014). Surgical Approaches and Outcome in the Treatment of the Obese Patients. In: Kushner, R., Bessesen, D. (eds) Treatment of the Obese Patient. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1203-2_17
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1203-2_17
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1202-5
Online ISBN: 978-1-4939-1203-2
eBook Packages: MedicineMedicine (R0)